Stable high-level expression of heterologous genes in vitro and in vivo by noncytopathic DNA-based Kunjin virus replicon vectors

Journal of Virology

Volumn 74, Issue 9, 2000, Pages 4394-4403

  Varnavski, Andrei N ^a   Young, Paul R ^a,b   Khromykh, Alexander A ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; PLASMID DNA; RNA; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; FLAVIVIRUS; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNIZATION; KUNJIN VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPLICON; RNA SYNTHESIS;

ANIMALS; CELL LINE; CELL LINE, TRANSFORMED; CERCOPITHECUS AETHIOPS; CRICETINAE; CYTOPATHOGENIC EFFECT, VIRAL; ENCEPHALITIS VIRUSES, JAPANESE; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC VECTORS; HEPATITIS DELTA VIRUS; HUMANS; KINETICS; MICE; REPLICON; RNA, CATALYTIC; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UBIQUITINS; VERO CELLS;

EID: 0034001812     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.9.4394-4403.2000     Document Type: Article

References (47)

1. Agapov, E. V., I. Frolov, B. D. Lindenbach, B. M. Pragai, S. Schlesinger, and C. M. Rice. 1998. Noncytopathic Sindbis virus RNA vectors for heterologous gene expression. Proc. Natl. Acad. Sci. USA 95:12989-12994.
2. Altman-Hamamdzic, S., C. Groseclose, J. X. Ma, D. Hamamdzic, N. S. Vrindavanam, L. D. Middaugh, N. P. Parratto, and F. R. Sallee. 1997. Expression of beta-galactosidase in mouse brain: utilization of a novel nonreplicative Sindbis virus vector as a neuronal gene delivery system. Gene Ther. 4:815-822.
3. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1994. Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
4. Bachmair, A., D. Finley, and A. Varshavsky. 1986. In vivo half-life of a protein is a function of its amino-terminal residue. Science 234:179-186.
5. Baker, R. T., S. A. Smith, R. Marano, J. McKee, and P. G. Board. 1994. Protein expression using cotranslational fusion and cleavage of ubiquitin. Mutagenesis of the glutathione-binding site of human Pi class glutathione S-transferase. J. Biol. Chem. 269:25381-25386.
6. Ball, L. A., and Y. Li. 1993. cis-acting requirements for the replication of flock house virus RNA 2. J. Virol. 67:3544-3551.
7. Berglund, P., C. Smerdou, M. N. Fleeton, I. Tubulekas, and P. Liljestrom. 1998. Enhancing immune responses using suicidal DNA vaccines. Nat. Biotechnol. 16:562-565.
8. Boshart, M., F. Weber, G. Jahn, K. Dorsch-Hasler, B. Fleckenstein, and W. Schaffner. 1985. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521-530.
9. Boyer, J.-C., and A.-L. Haenni. 1994. Infectious transcripts and cDNA clones of RNA viruses. Virology 198:415-426.
10. Bredenbeek, P., I. Frolov, C. M. Rice, and S. Schlesinger. 1993. Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs. J. Virol. 67:6439-6446.
11. Bredenbeek, P., and C. M. Rice. 1992. Animal RNA virus expression systems. Semin. Virol. 3:297-310.
12. Caley, I. J., M. R. Betts, D. M. Irlbeck, N. L. Davis, R. Swanstrom, J. A. Frelinger, and R. E. Johnston. 1997. Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector. J. Virol. 71:3031-3038.
13. Der, S. D., Y. L. Yang, C. Weissmann, and B. R. Williams. 1997. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc. Natl. Acad. Sci. USA 94:3279-3283.
14. DiCiommo, D. P., and R. Bremner. 1998. Rapid, high level protein production using DNA-based Semliki Forest virus vectors. J. Biol. Chem. 273: 18060-18066.
15. Dubensky, T. W., Jr., D. A. Driver, J. M. Polo, B. A. Belli, E. M. Latham, C. E. Ibanez, S. Chada, D. Brumm, T. A. Banks, S. J. Mento, D. J. Jolly, and S. M. W. Chang. 1996. Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer. J. Virol. 70:508-519.
16. Finch, J. S., K. Bonham, P. Krieg, and G. T. Bowden. 1990. Murine polyubiquitin mRNA sequence. Nucleic Acids Res. 18:1907.
17. Frolov, I., E. Agapov, T. A. Hoffman, Jr., B. M. Pragai, M. Lippa, S. Schlesinger, and C. M. Rice. 1999. Selection of RNA replicons capable of persistent noncytopathic replication in mammalian cells. J. Virol. 73:3854-3865.
18. Frolov, I., and S. Schlesinger. 1994. Comparison of the effects of Sindbis virus and Sindbis virus replicons on host cell protein synthesis and cytopathogenicity in BHK cells. J. Virol. 68:1721-1727.
19. Hariharan, M. J., D. A. Driver, K. Townsend, D. Brumm, J. M. Polo, B. A. Belli, D. J. Catton, D. Hsu, D. Mittelstaedt, J. K. McCormack, L. Karavodin, T. W. Dubensky, Jr., S. M. W. Chang, and T. A. Banks. 1998. DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector. J. Virol. 72:950-958.
20. Johanning, F. M., R. M. Conry, A. F. LoBuglio, M. Wright, L. A. Sumerel, M. J. Pike, and D. T. Curiel. 1995. A sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expression in vivo. Nucleic Acids Res. 23:1495-1501.
21. Johnson, K. L., and L. A. Ball. 1997. Replication of flock house virus RNAs from primary transcripts made in cells by RNA polymerase II. J. Virol. 71:3323-3327.
22. Johnson, K. L., and L. A. Ball. 1999. Induction and maintenance of autonomous flock house virus RNA1 replication. J. Virol. 73:7933-7942.
23. Karreman, C. 1998. Fusion PCR, a one-step variant of the "Mega-primer" method of mutagenesis. BioTechniques 24:736-742.
24. Khromykh, A. A., and E. G. Westaway. 1994. Completion of Kunjin virus RNA sequence and recovery of an infectious RNA transcribed from stably cloned full-length cDNA. J. Virol. 68:4580-4588.
25. Khromykh, A. A., and E. G. Westaway. 1997. Subgenomic replicons of the flavivirus Kunjin: construction and applications. J. Virol. 71:1497-1505.
26. Khromykh, A. A., M. T. Kenney, and E. G. Westaway. 1998. trans-complementation of flavivirus RNA polymerase gene NS5 by using Kunjin virus replicon-expressing BHK cells. J. Virol. 72:7270-7279.
27. Khromykh, A. A., A. N. Varnavski, and E. G. Westaway. 1998. Encapsidation of the flavivirus Kunjin replicon RNA by using a complementation system providing Kunjin structural proteins in trans. J. Virol. 72:5967-5977.
28. King, N. J., and A. M. Kesson. 1988. Interferon-independent increases in class I major histocompatibility complex antigen expression follow flavivirus infection. J. Gen. Virol. 69:2535-2543.
29. Liljestrom, P., and H. Garoff. 1991. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Bio/Technology 9:1356-1361.
30. Mackenzie, J. M., A. A. Khromykh, M. K. Jones, and E. G. Westaway. 1998. Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A. Virology 245:203-215.
31. Mullbacher, A., and M. Lobigs. 1995. Up-regulation of MHC class I by flavivirus-induced peptide translocation into the endoplasmic reticulum. Immunity 3:207-214.
32. Palese, P. 1998. RNA virus vectors: where are we and where do we need to go? Proc. Natl. Acad. Sci. USA 95:12750-12752.
33. Pattnaik, A. K., L. A. Ball, A. W. LeGrone, and G. W. Wertz. 1992. Infectious defective interfering particles of VSV from transcripts of a cDNA clone. Cell 69:1011-1020.
34. Percy, N., W. S. Barclay, M. Sullivan, and J. W. Almond. 1992. A poliovirus replicon containing the chloramphenicol acetyltransferase gene can be used to study the replication and encapsidation of poliovirus RNA. J. Virol. 66:5040-5046.
35. Perrotta, A. T., and M. D. Been. 1991. A pseudoknot-like structure required for efficient self-cleavage of hepatitis delta virus RNA. Nature (London) 350:434-436.
36. Porter, D. C., D. C. Ansardi, W. S. Choi, and C. D. Morrow. 1993. Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection. J. Virol. 67:3712-3719.
37. Pushko, P., M. Parker, G. V. Ludwig, N. L. Davis, R. E. Johnston, and J. F. Smith. 1997. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogenes in vivo. Virology 239:389-401.
38. Rodriguez, F., J. Zhang, and J. L. Whitton. 1997. DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction. J. Virol. 71:8497-8503.
39. Ryan, M. D., and J. Drew. 1994. Foot- and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein. EMBO J. 13:928-933.
40. Ryan, M. D., A. M. Q. King, and G. P. Thomas. 1991. Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. J. Gen. Virol. 72:2727-2732.
41. Shen, J., S. S. T-To, L. Schrieber, and N. J. C. King. 1997. Early E-selecin, VCAM-1, ICAM-1, and late major histocompatibility complex antigene induction on human endothelial cells by flavivirus and comodulation of adhesion molecule expression by immune cytokines. J. Virol. 71:9323-9332.
42. Vara, J. A., A. Portela, J. Ortin, and A. Jimenez. 1986. Expression in mammalian cells of a gene from Streptomyces alboniger conferring puromycin resistance. Nucleic Acids Res. 14:4617-4624.
43. Varnavski, A. N., and A. A. Khromykh. 1999. Noncytopathic flavivirus replicon RNA-based system for expression and delivery of heterologous genes. Virology 255:366-375.
44. Vilcek, J., and G. C. Sen. 1996. Interferons and other cytokines. p. 375-399. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
45. Westaway, E. G., J. M. Mackenzie, M. T. Kenney, M. K. Jones, and A. A. Khromykh. 1997. Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures. J. Virol. 71:6650-6661.
46. Wu, H.-N., and M. M. C. Lai. 1990. RNA conformational requirements of self-cleavage of hepatitis delta virus RNA. Mol. Cell. Biol. 10:5575-5579.
47. Ying, H., T. Z. Zaks, R.-F. Wang, K. R. Irvine, U. S. Kammula, F. M. Marincola, W. W. Leitner, and N. P. Pestifo. 1999. Cancer therapy using a self-replicating RNA vaccine. Nat. Med. 7:823-827.